Posts by John

Investigation reveals fraudulent paper mill studies are corrupting clinical guidelines and health policies. Learn how this threatens evidence-based medicine.

Groundbreaking research explores training the immune system to control HIV-1, potentially eliminating the need for daily medication. Learn about the future.

Clinical trials are facing major recruitment hurdles. Explore modern strategies, including decentralized trials and data-driven methods, to boost enrollment.

Roche’s Lunsumio achieves positive confirmatory trial results for follicular lymphoma, strengthening its role as a key bispecific immunotherapy.

Insilico Medicine has released its AI-driven longevity toolkit for global researchers, aiming to accelerate the discovery of new anti-aging therapies.

New research suggests intermittent fasting may clear toxic proteins and delay motor symptoms in Huntington’s disease, offering new hope for treatment.

New Phase II trial results show promising clinical efficacy for an adaptive immunotherapy and VEGFR-TKI combination in treating advanced renal cell carcinoma.

Massive Bio launches its AI-driven clinical trial platform in South Korea, aiming to accelerate oncology research and improve patient trial enrollment.

Maharashtra’s FDA moves to cap medical device prices, sparking intense debate between advocates for patient affordability and industry innovation leaders.

Acelot has launched Phase Ia trials for ACE-2223, a first-in-class oral drug targeting TDP-43 aggregates in ALS patients. Learn about this new research.